ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Detail of the clinical trial

Title of the trial Multiple Part Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma Subjects
EudraCT number 2020-004027-17
Protocol number SGN35-027
Sponsor Seagen Inc., 21823 30th Drive SE, Bothell, WA 98021, United states of America
Indications Hemato-oncology
Diagnosis Hodgkin Lymphoma
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Year of receiving the request to Institute (SÚKL) 2021
Date of approval by Institute (SÚKL) 19. 8. 2021
Date of approval by EC 23. 9. 2021
Date of initiation CT in ČR 5.4.2022
Date of ending CT in ČR
Sites Fakultní nemocnice Brno,Interní hematoonkologická klinika,Jihlavská 20,Brno,625 00
Všeobecná fakultní nemocnice,I.interní klinika, U nemocnice 2,Praha 2,128 08
Fakultní nemocnice Královské Vinohrady,Hematologická klinika,Šrobárova 1150/50,Praha 10,100 34
Fakultní nemocnice Hradec Králové, IV. interní klinika,Sokolská 581,Hradec Králové, 500 05

‹‹ Back to list